ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021

03 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

25 Oct 2021 16:01:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO Conference

22 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock

21 Oct 2021 09:00:11 By Nasdaq GlobeNewswire

ADMA Biologics Announces Proposed Public Offering of Common Stock

20 Oct 2021 16:01:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference

19 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

18 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021

04 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Announces Presentation on Respiratory Viral Infections at IDWeek 2021

01 Oct 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Cantor Healthcare Conference

23 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations

08 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Virtually Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

02 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN

16 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports Record Second Quarter 2021 Financial Results and Highlights Recent Progress and Accomplishments

11 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System

10 Aug 2021 16:30:00 By Nasdaq GlobeNewswire

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®

09 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021

04 Aug 2021 07:00:03 By Nasdaq GlobeNewswire

ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

20 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

14 Jun 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference

26 May 2021 07:00:01 By Nasdaq GlobeNewswire